According to Aileron Therapeutics 's latest financial reports the company's current EPS (TTM) is -$3.88. In 2022 the company made an earnings per share (EPS) of -$8.20 a decrease over its 2021 EPS that were of -$7.72.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$3.84 | -53.19% |
2022 | -$8.20 | 6.15% |
2021 | -$7.72 | -54.84% |
2020 | -$17.10 | -50.78% |
2019 | -$34.74 | -40.19% |
2018 | -$58.08 | -82.47% |
2017 | -$331.33 | 632.19% |
2016 | -$45.25 |